Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2017, Article ID 3495293, 6 pages
https://doi.org/10.1155/2017/3495293
Research Article

The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis

Federal State Budget Institution “Bakulev National Scientific and Practical Center for Cardiovascular Surgery” of the Ministry of Healthcare of the Russian Federation (Bakulev NSPCCS), Moscow, Russia

Correspondence should be addressed to Michael Yaroustovsky; ur.xednay@raybm

Received 31 January 2017; Revised 20 February 2017; Accepted 26 March 2017; Published 12 April 2017

Academic Editor: B. L. Slomiany

Copyright © 2017 Michael Yaroustovsky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. M. Arabi, S. I. Dara, H. M. Tamim et al., “Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study,” Critical Care, vol. 17, no. 2, article R72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Valerio-Rojas, I. J. Jaffer, D. J. Kor, O. Gajic, and R. Cartin-Ceba, “Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study,” Critical Care Research and Practice, vol. 2013, Article ID 782573, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K.-M. Kaukonen, M. Bailey, S. Suzuki, D. Pilcher, and R. Bellomo, “Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012,” JAMA, vol. 311, no. 13, pp. 1308–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. De Oliveira, J. B. De Oliveira Filho, R. Ferreira Silva et al., “Sepsis in the postoperative period of cardiac surgery: problem description,” Arquivos Brasileiros de Cardiologia, vol. 94, no. 3, pp. 332–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Curiel-Balsera, J. M. Mora-Ordoñez, E. Castillo-Lorente et al., “Mortality and complications in elderly patients undergoing cardiac surgery,” Journal of Critical Care, vol. 28, no. 4, pp. 397–404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Popov and T. Vostrikova, “Microbiological monitoring in cardiac surgery hospital—a ten-year experience,” The Bulletin of A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Russian Academy of Medical Sciences, vol. 5, no. 13, pp. 68–76, 2012. View at Google Scholar
  7. S. M. Opal and T. Calandra, “Antibiotic usage and resistance: Gaining or losing ground on infections in critically ill patients?” JAMA, vol. 302, no. 21, pp. 2367–2368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Takeda, “Evolution and integration of innate immune recognition systems: the Toll-like receptors,” Journal of Endotoxin Research, vol. 11, no. 1, pp. 51–55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Tressel, N. C. Kaneider, S. Kasuda et al., “A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis,” EMBO Molecular Medicine, vol. 3, no. 7, pp. 370–384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Christaki and E. J. Giamarellos-Bourboulis, “The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host,” Virulence, vol. 5, no. 1, pp. 57–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. D. N. Cruz, M. Antonelli, R. Fumagalli et al., “Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial,” JAMA, vol. 301, no. 23, pp. 2445–2452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Klein, D. Foster, C. A. Schorr, K. Kazempour, P. M. Walker, and R. P. Dellinger, “The EUPHRATES trial (evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock): study protocol for a randomized controlled trial,” Trials, vol. 15, no. 1, article 218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Yaroustovsky, M. Abramyan, N. Krotenko et al., “Combined extracorporeal therapy for severe sepsis in patients after cardiac surgery,” Blood Purification, vol. 37, no. 1, pp. 39–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. D. Romaschin, D. M. Harris, M. B. Ribeiro et al., “A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence,” Journal of Immunological Methods, vol. 212, no. 2, pp. 169–185, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Yaroustovsky, M. Plyushch, D. Popov et al., “Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery,” Journal of Inflammation (United Kingdom), vol. 10, no. 1, article 8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Google Scholar
  17. Т. Lang and М. Secic, “How to report statistics in medicine,” in Annotated Guidelines for Authors, Editors, and Reviewers, T. Lang and M. Secic, Eds., p. 480, Practical Medicine, Мoscow, Russia, 2011. View at Google Scholar
  18. Clinical Chemistry Guide to Scientific Writing, https://www.aacc.org/publications/clinical-chemistry/clinical-chemistry%C2%A0guide-to-scientific-writing.
  19. R. C. Allen, “[36] Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis,” Methods in Enzymology, vol. 133, pp. 449–493, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Chenevier-Gobeaux, D. Borderie, N. Weiss, T. Mallet-Coste, and Y.-E. Claessens, “Presepsin (sCD14-ST), an innate immune response marker in sepsis,” Clinica Chimica Acta, vol. 450, pp. 97–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. P. H. C. Leliefeld, C. M. Wessels, L. P. H. Leenen, L. Koenderman, and J. Pillay, “The role of neutrophils in immune dysfunction during severe inflammation,” Critical Care, vol. 20, no. 1, article 73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sadallah, C. Hess, S. Miot, O. Spertini, H. Lutz, and J.-A. Schifferli, “Elastase and metalloproteinase activities regulate soluble complement receptor 1 release,” European Journal of Immunology, vol. 29, no. 11, pp. 3754–3761, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Belotsky and R. Avtalion, The Inflammation. Cellular Mobilization and Clinical Effects, Publishing House BINOM, Moscow, Russia, 2008.
  24. B. Kuznik, Cellular and Molecular Mechanisms of Regulation of the Hemostasis System in the Healthy Body and in the Disease: Monograph, Express, Chita, Russia, 2010.
  25. Y. Arai, K. Mizugishi, K. Nonomura, K. Naitoh, A. Takaori-Kondo, and K. Yamashita, “Phagocytosis by human monocytes is required for the secretion of presepsin,” Journal of Infection and Chemotherapy, vol. 21, no. 8, pp. 564–569, 2015. View at Publisher · View at Google Scholar · View at Scopus